The landscape of dementia analysis has advanced substantially with the advent of subtle biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent checks that may detect Alzheimer's pathology a long time in advance of symptoms emerge. Even though these technological innovations symbolize amazing progress in knowing neurodegenera